Filing Details

Accession Number:
0001179110-11-011939
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-09 13:00:00
Reporting Period:
2011-08-05
Filing Date:
2011-08-09
Accepted Time:
2011-08-09 17:11:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239126 C Thomas Freyman 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Disposition 2011-08-05 9,500 $49.19 375,203 No 4 S Direct
Common Shares Without Par Value Disposition 2011-08-05 100 $49.19 375,103 No 4 S Direct
Common Shares Without Par Value Disposition 2011-08-05 100 $49.19 375,003 No 4 S Direct
Common Shares Without Par Value Disposition 2011-08-05 100 $49.19 374,903 No 4 S Direct
Common Shares Without Par Value Disposition 2011-08-05 10,200 $49.19 364,703 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 1,001 Indirect Profit Sharing Trust
Common Shares Without Par Value 15,000 Indirect Annette Newton-Freyman 1994 Trust
Common Shares Without Par Value 1,941 Indirect By daughter
Common Shares Without Par Value 1,941 Indirect By spouse as trustee for son
Common Shares Without Par Value 1,941 Indirect By spouse as trustee for son
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of August 5, 2011.
  2. Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
  3. The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.